Research & Literature

Symptoms in women with Peripartum Cardiomyopathy: A mixed method study.

Patel H, Berg M, Barasa A, et al.

Midwifery 2016; (32()):14-20.

Clinical Characteristics and Prognosis of Peripartum Cardiomyopathy in 28 Patients.

Liu Y, Zeng Y

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2016; (38(1)):78-82 doi:10.3881/j.issn.1000-503X.2016.01.014.

The Search for a Crystal Ball to Predict Early Recovery From Peripartum Cardiomyopathy?

Elkayam U, Habakuk O

JACC. Heart failure 2016; (4(5)):389-91.

Quality of Life in Survivors of Peripartum Cardiomyopathy.

Koutrolou-Sotiropoulou P, Lima FV, Stergiopoulos K

The American journal of cardiology 2016; (118(2)):258-63.

Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.

Melo MA, Carvalho JS, Feitosa FE, et al.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2016; (38(6)):308-13 doi:10.1055/s-0036-1584567.

All that wheezes is not asthma: A cautionary case study of shortness of breath in pregnancy.

Varnier NA, Chwah S, Miller T, et al.

Obstetric medicine 2015; (8(3)):149-51 doi:10.1177/1753495X15590020.

Can Bedside Ultrasound Inferior Vena Cava Measurements Accurately Diagnose Congestive Heart Failure in the Emergency Department? A Clin-IQ.

Gaskamp M, Blubaugh M, McCarthy LH, Scheid DC

Journal of patient-centered research and reviews 2016; (3(4)):230-234.

Experiences of health care in women with Peripartum Cardiomyopathy in Sweden: a qualitative interview study.

Patel H, Schaufelberger M, Begley C, Berg M

BMC pregnancy and childbirth 2016; (16(1)):386 doi:10.1186/s12884-016-1178-3.

Titin-truncating mutations in dilated cardiomyopathy: the long and short of it.

Fatkin D, Huttner IG

Current opinion in cardiology 2017; (32(3)):232-238 doi:10.1097/HCO.0000000000000382.

Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy.

Hilfiker-Kleiner D, Haghikia A, Masuko D, et al.

European journal of heart failure 2017; (19(12)):1723-1728 doi:10.1002/ejhf.808.

Depression and health behaviors in women with Peripartum Cardiomyopathy.

Rosman L, Salmoirago-Blotcher E, Cahill J, et al.

Heart & lung : the journal of critical care 2017; (46(5)):363-368 doi:10.1016/j.hrtlng.2017.05.004.

Peripartum cardiomyopathy, what if your patient plans to reconceive?

Al Bannay R, Husain A, AlJufairi Z

Clinical case reports 2017; (5(6)):753-756 doi:10.1002/ccr3.935.

Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high-dose bromocriptine therapy.

Horn P, Saeed D, Akhyari P, et al.

ESC heart failure 2017; (4(4)):641-644 doi:10.1002/ehf2.12175.

A contemporary review of peripartum cardiomyopathy.

Patel PA, Roy A, Javid R, Dalton JA

Clinical medicine (London, England) 2017; (17(4)):316-321 doi:10.7861/clinmedicine.17-4-316.

Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD.

Arrigo M, Blet A, Mebazaa A

European heart journal 2017; (38(35)):2680-2682 doi:10.1093/eurheartj/ehx428.

Subsequent Pregnancy Outcomes in Patients With Peripartum Cardiomyopathy.

Codsi E, Rose CH, Blauwet LA

Obstetrics and gynecology 2018; (131(2)):322-327 doi:10.1097/AOG.0000000000002439.

Heart Transplantation for Peripartum Cardiomyopathy: A Single-Center Experience.

Bouabdallaoui N, Demondion P, Maréchaux S, et al.

Arquivos brasileiros de cardiologia 2018; (110(2)):181-187 doi:10.5935/abc.20180014.

A Population-based Study of Peripartum Cardiomyopathy in Southern Israel: Are Bedouin Women a New High-risk Group?

Kezerle L, Sagy I, Shalev L, et al.

Rambam Maimonides medical journal 2018; (9(2)) doi:10.5041/RMMJ.10331.

Peripartum cardiomyopathy: approach to management.

Goland S, Elkayam U

Current opinion in cardiology 2018; (33(3)):347-353 doi:10.1097/HCO.0000000000000516.

Psychological adaptation after peripartum cardiomyopathy: A qualitative study.

de Wolff M, Ersbøll AS, Hegaard H, et al.

Midwifery 2018; (62()):52-60 doi:10.1016/j.midw.2018.03.012.

New Insights in Peripartum Cardiomyopathy.

Cruz MO, Briller J, Hibbard JU

Obstetrics and gynecology clinics of North America 2018; (45(2)):281-298 doi:10.1016/j.ogc.2018.02.002.

Peripartum cardiomyopathy: A systematic review of the literature.

Asad ZUA, Maiwand M, Farah F, Dasari TW

Clinical cardiology 2018; (41(5)):693-697 doi:10.1002/clc.22932.

Predictors of early and delayed recovery in peripartum cardiomyopathy: a prospective study of 52 Patients.

Biteker M, Özlek B, Özlek E, et al.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2020; (33(3)):390-397 doi:10.1080/14767058.2018.1494146.

One-Year Cardiovascular Outcomes in Patients With Peripartum Cardiomyopathy.

Dayoub EJ, Datwani H, Lewey J, Groeneveld PW

Journal of cardiac failure 2018; (24(10)):711-715 doi:10.1016/j.cardfail.2018.08.005.

Peripartum Cardiomyopathy: a Review for the Clinician.

Khan A, Paré E, Shah S

Current treatment options in cardiovascular medicine 2018; (20(11)):91 doi:10.1007/s11936-018-0690-3.

Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.

Ersbøll AS, Bojer AS, Hauge MG, et al.

Journal of the American Heart Association 2018; (7(20)):e008991 doi:10.1161/JAHA.118.008991.

Cardiomyopathies and Congenital Heart Disease in Pregnancy.

Westhoff-Bleck M, Hilfiker-Kleiner D, Pankuweit S, Schieffer B

Geburtshilfe und Frauenheilkunde 2018; (78(12)):1256-1261 doi:10.1055/a-0774-8696.

Titin-truncating variants are associated with heart failure events in patients with left ventricular non-compaction cardiomyopathy.

Li S, Zhang C, Liu N, et al.

Clinical cardiology 2019; (42(5)):530-535 doi:10.1002/clc.23172.

Life-threatening peripartum cardiomyopathy-Not expected when expecting.

Magnusson P, Kihlström G, Wallhagen M, Rambaree K

Clinical case reports 2019; (7(6)):1127-1132 doi:10.1002/ccr3.2158.

Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.

Bauersachs J, König T, van der Meer P, et al.

European journal of heart failure 2019; (21(7)):827-843 doi:10.1002/ejhf.1493.

Anticoagulation for intra-cardiac thrombi in peripartum cardiomyopathy: A review of the literature.

Agrawal A, Jain D, Ram P, et al.

Reviews in cardiovascular medicine 2019; (20(2)):53-58 doi:10.31083/j.rcm.2019.02.55.

July 2019 at a glance: imaging of congestion, sodium-glucose co-transporter 2 inhibitors, myocardial function and MitraClip trials.

Metra M

European journal of heart failure 2019; (21(7)):821-822 doi:10.1002/ejhf.1266.

Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers.

Kavsak PA, Lam CSP, Saenger AK, et al.

Clinical chemistry 2019; (65(10)):1221-1227 doi:10.1373/clinchem.2019.306621.

Management of Heart Failure and Cardiogenic Shock in Pregnancy.

Sharma S, Thomas SS

Current treatment options in cardiovascular medicine 2019; (21(12)):83 doi:10.1007/s11936-019-0797-1.

SONO case series: a 63-year-old male with shortness of breath.

Lin-Martore M, Anaya N

Emergency medicine journal : EMJ 2021; (38(2)):155-157 doi:10.1136/emermed-2019-209095.

Post-Traumatic Stress, Depression, and Quality of Life in Women with Peripartum Cardiomyopathy.

Donnenwirth JA, Hess R, Ross R

MCN. The American journal of maternal child nursing 2020; (45(3)):176-182 doi:10.1097/NMC.0000000000000614.

The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation.

Aguayo-Cerón KA, Calzada-Mendoza CC, Méndez-Bolaina E, et al.

Clinical and experimental hypertension (New York, N.Y. : 1993) 2020; (42(7)):675-679 doi:10.1080/10641963.2020.1772814.

Racial disparities in peripartum cardiomyopathy: eighteen years of observations.

Sinkey RG, Rajapreyar IN, Szychowski JM, et al.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022; (35(10)):1891-1898 doi:10.1080/14767058.2020.1773784.

Inhibition of the Notch1 pathway induces peripartum cardiomyopathy.

Zhu RR, Chen Q, Liu ZB, et al.

Journal of cellular and molecular medicine 2020; (24(14)):7907-7914 doi:10.1111/jcmm.15423.

Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.

Sliwa K, Petrie MC, van der Meer P, et al.

European heart journal 2020; (41(39)):3787-3797 doi:10.1093/eurheartj/ehaa455.

BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era.

Sbolli M, deFilippi C

Current cardiology reports 2020; (22(11)):150 doi:10.1007/s11886-020-01398-8.

Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review.

Chinweuba GC, Rutkofsky IH

Cureus 2020; (12(10)):e10790 doi:10.7759/cureus.10790.

Burden, predictors and short-term outcomes of peripartum cardiomyopathy in a black African cohort.

Nabbaale J, Okello E, Kibirige D, et al.

PloS one 2020; (15(10)):e0240837 doi:10.1371/journal.pone.0240837.

Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India.

Binu AJ, Rajan SJ, Rathore S, et al.

Obstetric medicine 2020; (13(4)):179-184 doi:10.1177/1753495X19851397.

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies.

Bueno H, Moura B, Lancellotti P, Bauersachs J

European heart journal 2021; (42(6)):657-670 doi:10.1093/eurheartj/ehaa1061.

Peripartum cardiomyopathy.

Jha N, Jha AK

Heart failure reviews 2021; (26(4)):781-797 doi:10.1007/s10741-020-10060-y.

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

Bozkurt B, Coats AJS, Tsutsui H, et al.

European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.

Goli R, Li J, Brandimarto J, et al.

Circulation 2021; (143(19)):1852-1862 doi:10.1161/CIRCULATIONAHA.120.052395.

Persistence of abnormal global longitudinal strain in women with peripartum cardiomyopathy.

Bortnick AE, Lama von Buchwald C, Hasani A, et al.

Echocardiography (Mount Kisco, N.Y.) 2021; (38(6)):885-891 doi:10.1111/echo.15071.

Peripartum cardiomyopathy: a review.

Iorgoveanu C, Zaghloul A, Ashwath M

Heart failure reviews 2021; (26(6)):1287-1296 doi:10.1007/s10741-020-10061-x.

Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.

Farhan HA, Yaseen IF

ESC heart failure 2021; (8(5)):4048-4054 doi:10.1002/ehf2.13502.

Peripartum cardiomyopathy: from genetics to management.

Sliwa K, Bauersachs J, Arany Z, et al.

European heart journal 2021; (42(32)):3094-3102 doi:10.1093/eurheartj/ehab458.

Peripartum cardiomyopathy and acute heart failure associated with prolonged tocolytic therapy in pregnancy: A case report.

Li PC, Chang HR, Kao SP

Medicine 2021; (100(34)):e27080 doi:10.1097/MD.0000000000027080.

A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy.

Badianyama M, Das PK, Gaddameedi SR, et al.

Cureus 2021; (13(9)):e18248 doi:10.7759/cureus.18248.

Truncated titin proteins in dilated cardiomyopathy.

McAfee Q, Chen CY, Yang Y, et al.

Science translational medicine 2021; (13(618)):eabd7287 doi:10.1126/scitranslmed.abd7287.

Pathophysiology and risk factors of peripartum cardiomyopathy.

Hoes MF, Arany Z, Bauersachs J, et al.

Nature reviews. Cardiology 2022; (19(8)):555-565 doi:10.1038/s41569-021-00664-8.

Heart rate as an early predictor of severe cardiomyopathy and increased mortality in peripartum cardiomyopathy.

Cooney R, Scott JR, Mahowald M, et al.

Clinical cardiology 2022; (45(2)):205-213 doi:10.1002/clc.23782.

Characterization of heart failure patients with reverse left ventricular remodelling post-angiotensin receptor blockers/neprilysin inhibitors therapy.

Maizels L, Wasserstrum Y, Fishman B, et al.

ESC heart failure 2022; (9(3)):1682-1688 doi:10.1002/ehf2.13801.

Peripartum cardiomyopathy: a review of current literature.

Simpson C, Mittal R, Jain R, Jain R

Future cardiology 2022; (18(4)):337-343 doi:10.2217/fca-2021-0045.

Peripartum Cardiomyopathy: Diagnostic and Prognostic Value of Cardiac Magnetic Resonance in the Acute Stage.

Isaak A, Ayub TH, Merz WM, et al.

Diagnostics (Basel, Switzerland) 2022; (12(2)) doi:10.3390/diagnostics12020378.

Subclinical myocardial dysfunction in patients with complete recovery from peripartum cardiomyopathy: a long-term clinical strain-echocardiographic study.

Akgoz H, Gurkan U

Hypertension in pregnancy 2022; (41(2)):89-96 doi:10.1080/10641955.2022.2046049.

NT-ProBNP and high-sensitivity troponin T as screening tests for subclinical chronic heart failure in a general population.

Averina M, Stylidis M, Brox J, Schirmer H

ESC heart failure 2022; (9(3)):1954-1962 doi:10.1002/ehf2.13906.

Peripartum Cardiomyopathy and Spouses' Experiences of Persistent Uncertainty.

Hess RF, Donnenwirth JA

MCN. The American journal of maternal child nursing 2022; (47(4)):207-212 doi:10.1097/NMC.0000000000000831.

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.

Pfeffer TJ, Mueller JH, Haebel L, et al.

ESC heart failure 2023; (10(1)):465-477 doi:10.1002/ehf2.14210.

The outcome of peripartum cardiomyopathy patients-single center experience.

Demir E, Ceylan N, Bayraktaroğlu S, et al.

Echocardiography (Mount Kisco, N.Y.) 2022; (39(12)):1608-1615 doi:10.1111/echo.15498.

Peripartum Cardiomyopathy.

Shrikhande L, Shrikhande A, Shrikhande B

Journal of obstetrics and gynaecology of India 2022; (72(5)):377-381 doi:10.1007/s13224-022-01621-2.

Prognostic Value of Cardiac MRI Late Gadolinium Enhancement in Patients with Peripartum Cardiomyopathy: A Retrospective Study.

Xu H, Zhao L, Fu H, et al.

Current problems in cardiology 2023; (48(4)):101587 doi:10.1016/j.cpcardiol.2023.101587.

[Case of peripartum cardiomyopathy misdiagnosed as pulmonary changes due to COVID-19].

Gavrilov DV, Bagirova ZR, Pleskatsevich DI, et al.

Kardiologiia 2022; (62(12)):80-84 doi:10.18087/cardio.2022.12.n1668.

Long-Term Outcomes of Women With Peripartum Cardiomyopathy Having Subsequent Pregnancies.

Pachariyanon P, Bogabathina H, Jaisingh K, et al.

Journal of the American College of Cardiology 2023; (82(1)):16-26 doi:10.1016/j.jacc.2023.04.043.

Heart failure due to peripartum cardiomyopathy presenting in the first week of puerperium-A case series from Nepal.

Banmala S, Awal S, Bata L, et al.

Clinical case reports 2024; (12(6)):e9043 doi:10.1002/ccr3.9043.

Postpartum cardiomyopathy with congestive heart failure: A case report.

Jayte M, Mohamud A, Dubad F

SAGE open medical case reports 2024; (12()):2050313X241263761 doi:10.1177/2050313X241263761.

Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology.

Sliwa K, Rakisheva A, Viljoen C, et al.

European journal of heart failure 2024; (26(10)):2143-2154 doi:10.1002/ejhf.3377.

Peripartum cardiomyopathy in the twenty-first century: a review of the pathophysiology and clinical trials for novel disease-specific therapeutics.

Callender K, Briggs LA

Heart failure reviews 2025; (30(2)):443-451 doi:10.1007/s10741-024-10475-x.

The Advances in Utilizing Right Ventricular Function as a Predictor of Peripartum Cardiomyopathy Recovery: A Single Centre Prospective Cohort Study.

Akbar MR, Sakasasmita S, Achmad C, et al.

International journal of general medicine 2025; (18()):299-308 doi:10.2147/IJGM.S477008.

Improving Outcomes in Peripartum Cardiomyopathy with Vericiguat: A Clinical Case.

Cacciapuoti F, Mauro C, Capone V, et al.

Journal of cardiovascular echography 2024; (34(4)):214-218 doi:10.4103/jcecho.jcecho_48_24.

TTN:c.12478del in proximal I-band of titin represents a common molecular cause of dilated cardiomyopathy in Slovenian patients.

Vodnjov N, Cerar A, Maver A, et al.

Orphanet journal of rare diseases 2025; (20(1)):92 doi:10.1186/s13023-025-03613-7.

Efficacy and safety of bromocriptine in peripartum cardiomyopathy: A systematic review and meta-analysis.

Attachaipanich T, Attachaipanich S, Kaewboot K

International journal of cardiology 2025; (427()):133105 doi:10.1016/j.ijcard.2025.133105.

Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: Diagnostic accuracy study.

Taylor CJ, Taylor KS, Jones NR, et al.

ESC heart failure 2025; (12(5)):3552-3568 doi:10.1002/ehf2.15383.